Friday - May 16, 2025
DENVER, May 4, 2023 /PRNewswire/ -- DaVita Inc. today published its 2022 Community Care Report, reinforcing its long-standing commitment to corporate citizenship and highlighting meaningful progress made toward meeting the 2025 environmental, social and governance (ESG) goals it set in 2021.
Guided by its Trilogy of Care – Caring for Our Patients, Caring for Each Other and Caring for Our World – DaVita's ambitious, values-based goals are organized across five strategic pillars:
In 2022, DaVita teammates drove initiatives that advanced its goals and held the company accountable to its commitment to better the communities it serves.
"As a Village, we envision a healthier, more vibrant and more equitable world and—more importantly—take action to help create it," says Javier Rodriguez, CEO of DaVita. "This report is a celebration not only of the progress we've made toward our Community Care goals but of our teammates, as our accomplishments are only possible because of their deeply rooted dedication."
Following are key 2022 milestones from each focus area reflected in the report.
Patient Care
Teammate Engagement1
Environmental Stewardship
Caring for Communities
Leading with Integrity & Accountability
To learn more about DaVita's vision for corporate citizenship or to download the full report, visit DaVita.com/CommunityCare.
Media:
Megan Anthony
Megan.Anthony@DaVita.com
720-631-2170
About DaVita
DaVita (NYSE: DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. The company is one of the largest providers of kidney care services in the U.S. and has been a leader in clinical quality and innovation for more than 20 years. DaVita cares for patients at every stage and setting along their kidney health journey—from slowing the progression of kidney disease to helping to support transplantation, from acute hospital care to dialysis at home. As of December 31, 2022, DaVita served 200,000 patients at 2,724 outpatient dialysis centers in the United States. The company also operated 350 outpatient dialysis centers in 11 other countries worldwide. DaVita has reduced hospitalizations, improved mortality, and worked collaboratively to propel the kidney care industry to adopt an equitable and high-quality standard of care for all patients, everywhere. To learn more, visit DaVita.com/About.
1 Teammate Engagement section data applies to US teammates as of December 31, 2022.
2 Spencer Stuart 2022 Board Index
Last Trade: | US$144.70 |
Daily Change: | 1.10 0.77 |
Daily Volume: | 266,638 |
Market Cap: | US$11.870B |
May 12, 2025 February 27, 2025 February 13, 2025 October 29, 2024 October 23, 2024 |
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MOREC4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MOREEnd of content
No more pages to load